Amivantamab compared with real-world therapies in patients with advanced non-small cell lung cancer harboring EGFR exon 20 insertion mutations who progressed after platinum-based chemotherapy-Reference-Cited by-同舟云学术

Amivantamab compared with real-world therapies in patients with advanced non-small cell lung cancer harboring EGFR exon 20 insertion mutations who progressed after platinum-based chemotherapy

Published:2022-06 Issue: Volume:168 Page:74-82
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Minchom Anna,Viteri Santiago,Bazhenova Lyudmila,Gadgeel Shirish M.,Ou Sai-Hong Ignatius,Trigo José,Bauml Joshua M.,Backenroth Daniel,Bhattacharya Archan,Li Tracy,Mahadevia Parthiv,Girard Nicolas

Funder

Janssen Research and Development

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference39 articles.

1. Diverse EGFR exon 20 insertions and co-occurring molecular alterations identified by comprehensive genomic profiling of NSCLC;Riess;J. Thorac. Oncol.,2018

2. Structural, biochemical, and clinical characterization of epidermal growth factor receptor (EGFR) exon 20 insertion mutations in lung cancer;Yasuda;Sci. Transl. Med.,2013

3. In vitro modeling to determine mutation specificity of EGFR tyrosine kinase inhibitors against clinically relevant EGFR mutants in non-small-cell lung cancer;Hirano;Oncotarget,2015

4. Impact of EGFR inhibitor in non-small cell lung cancer on progression-free and overall survival: a meta-analysis;Lee;J. Natl. Cancer Inst.,2013

5. Phase II study of osimertinib in NSCLC patients with EGFR exon 20 insertion mutation: A multicenter trial of the Korean Cancer Study Group (LU17-19);Kim;Ann. Oncol.,2021

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Indirect comparison of capmatinib treatment from GEOMETRY mono-1 trial to SOC in German patients with locally advanced or metastatic NSCLC harboring METex14 skipping mutations;European Journal of Cancer;2024-08

2. Amivantamab: A Novel Advance in the Treatment of Non-small Cell Lung Cancer;Cureus;2024-05-22

3. Clinical outcomes in patients with non-small cell lung cancer harboring EGFR Exon20 in-frame insertions in the near-loop and far-loop: Results from LC-SCRUM-Asia;Lung Cancer;2024-05

4. Efficacy and safety of bispecific antibodies vs. immune checkpoint blockade combination therapy in cancer: a real-world comparison;Molecular Cancer;2024-04-16

5. Combinatorial Approaches for Chemotherapies and Targeted Therapies With Radiation: United Efforts to Innovate in Patient Care;International Journal of Radiation Oncology*Biology*Physics;2024-04